BioSpace News Archive

Deals

Massachusetts’ Quanterix Hopes $74M IPO Will Help Drive Biotech, Pharma Biz

The company believes its ultrasensitive immunoassay technology is well-suited to pharma research.

January 19, 2018
·
1 min read
BioCapital

New $500 Blood Test Can Detect 8 Cancers Before Symptoms Develop

The researchers took blood samples from 1,005 people with one of the eight different cancer types.

January 19, 2018
·
1 min read
Job Trends

Most-Wanted Life Sciences Employers in Genetown

Life sciences professionals don’t have to look far for opportunity in Genetown.

January 19, 2018
·
4 min read
·
Jennifer Fink
Pharm Country

First-Time Data for Merck’s KEYTRUDA (pembrolizumab) in Patients with Previously Treated Advanced Hepatocellular Carcinoma (HCC) to be Presented at 2018 ASCO GI Symposium

Merck today announced findings from the registrational phase 2 KEYNOTE-224 trial investigating the use of KEYTRUDA (pembrolizumab).

January 19, 2018
·
26 min read
Oramed Pharma’s CEO Issues Letter to Shareholders

2017 Major Milestones Achieved

January 19, 2018
·
6 min read
Business

Adlai Nortye Enters into Global Licensing Agreement With Eisai for EP4 Antagonist

Under the terms of the Agreement, Adlai Nortye will have exclusive worldwide research, development, manufacture and commercialization rights to E7046, excluding Japan and part of Asia other than Mainland China.

January 19, 2018
·
3 min read
Pharm Country

PAVmed Announces Pricing of Firm Commitment Common Stock Offering

PAVmed announced the pricing of its previously announced underwritten public offering of 2,415,278 shares of its common stock at a price to the public of $1.80 per share. In addition,

January 19, 2018
·
4 min read
Policy

Locate Therapeutics Successfully Achieves ISO 13845 Certification for Design, Development and Control of Manufacture for Resorbable Biomaterials

Locate Therapeutics has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration.

January 19, 2018
·
2 min read
Business

UPM Pharma Appoints Chris Curtin as COO

Mr. Curtin was promoted from his previous role as Executive VP of Quality Operations.

January 19, 2018
·
2 min read
Drug Development

Orphazyme’s Arimoclomol for NPC Receives Rare Pediatric Disease Designation

NPC is a genetic disease affecting around 1 in 120,000 newborns.

January 19, 2018
·
3 min read